Literature DB >> 19218198

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

Patrick Eldin1,2,3, Laura Papon1,2,3, Alexandra Oteiza1,2,3, Emiliana Brocchi4, T Glen Lawson5, Nadir Mechti1,2,3.   

Abstract

The interferon (IFN) system is a major effector of the innate immunity that allows time for the subsequent establishment of an adaptive immune response against a wide-range of pathogens. Their diverse biological actions are thought to be mediated by the products of specific but usually overlapping sets of cellular genes induced in the target cells. Ubiquitin ligase members of the tripartite motif (TRIM) protein family have emerged as IFN-induced proteins involved in both innate and adaptive immunity. In this report, we provide evidence that TRIM22 is a functional E3 ubiquitin ligase that is also ubiquitinated itself. We demonstrate that TRIM22 expression leads to a viral protection of HeLa cells against encephalomyocarditis virus infections. This effect is dependent upon its E3 ubiquitinating activity, since no antiviral effect was observed in cells expressing a TRIM22-deletion mutant defective in ubiquitinating activity. Consistent with this, TRIM22 interacts with the viral 3C protease (3C(PRO)) and mediates its ubiquitination. Altogether, our findings demonstrate that TRIM22 E3 ubiquitin ligase activity represents a new antiviral pathway induced by IFN against picornaviruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218198     DOI: 10.1099/vir.0.006288-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  57 in total

1.  Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.

Authors:  Bo Gao; Wei Xu; Yaxin Wang; Linmao Zhong; Sidong Xiong
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

Review 2.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

3.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.

Authors:  Christopher O'Connor; Thomas Pertel; Seth Gray; Seth L Robia; Joanna C Bakowska; Jeremy Luban; Edward M Campbell
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

Review 6.  TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.

Authors:  Ricardo Rajsbaum; Adolfo García-Sastre; Gijs A Versteeg
Journal:  J Mol Biol       Date:  2013-12-12       Impact factor: 5.469

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

8.  Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Neelam Dhiman; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2009-11-10       Impact factor: 4.132

10.  TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kunikazu Tanji; Tetsu Kamitani; Fumiaki Mori; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.